Home > Quotes > CRME

Cardiome Pharma Corporation Ordinary Shares (Canada) Quote & Summary Data

CRME 
$4.47
*  
0.05
1.11%
Get CRME Alerts
*Delayed - data as of Apr. 29, 2016  -  Find a broker to begin trading CRME now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Cardiome Pharma Corporation Ordinary Shares (Canada) Intraday Chart




News for CRME

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 4.58 $ 10.40
Low $ 4.37 $ 3.70

The current last sale of $4.47 is 20.81% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are a specialty pharmaceutical company dedicated to the development and commercialization of cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. We strive to find innovative, differentiated medicines that provide therapeutic and economic value to patients, physicians and healthcare systems. We currently have two marketed, in-hospital cardiology products, BRINAVESSTM and AGGRASTAT®, which are commercially available in markets outside of the United States, and commercialization rights to marketed cardiology products, ESMOCARD® and ESMOCARD LYO® (esmolol hydrochloride), in certain European countries. We have also licensed commercialization rights to a drug/device combination product, TREVYENT®, for the treatment of pulmonary arterial hypertension ("PAH") in certain regions outside the United States.  ... More ...  

Risk Grade

Where does CRME fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?